Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Maki, Carl
One or more keywords matched the following items that are connected to Maki, Carl
Item TypeName
Concept CDC2 Protein Kinase
Concept Protein Kinase Inhibitors
Concept Proto-Oncogene Proteins c-akt
Concept Protein Kinase C-epsilon
Academic Article The prolyl peptidases PRCP/PREP regulate IRS-1 stability critical for rapamycin-induced feedback activation of PI3K and AKT.
Academic Article Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.
Academic Article Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor.
Academic Article Transient nutlin-3a treatment promotes endoreduplication and the generation of therapy-resistant tetraploid cells.
Academic Article Glucocorticoid receptor activation inhibits p53-induced apoptosis of MCF10Amyc cells via induction of protein kinase Ce.
Academic Article Two 4N cell-cycle arrests contribute to cisplatin-resistance.
Academic Article The IGF-1R/AKT pathway has opposing effects on Nutlin-3a-induced apoptosis.
Academic Article p53 promotes AKT and SP1-dependent metabolism through the pentose phosphate pathway that inhibits apoptosis in response to Nutlin-3a.
Academic Article Prolyl endopeptidase inhibitor Y-29794 blocks the IRS1-AKT-mTORC1 pathway and inhibits survival and in vivo tumor growth of triple-negative breast cancer.
Academic Article Fatty acid oxidation and autophagy promote endoxifen resistance and counter the effect of AKT inhibition in ER-positive breast cancer cells.
Academic Article Mixed lineage kinase 3 and CD70 cooperation sensitize trastuzumab-resistant HER2+ breast cancer by ceramide-loaded nanoparticles.
Search Criteria
  • Proto Oncogene Proteins c akt